Profund Advisors LLC Amylyx Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$2.71 - $19.57 $109,381 - $789,884	40,362 Added 164.03%	64,969 $184,000
Q4 2023 Feb 14, 2024	BUY	$12.07 - $18.46 $63,234 - $96,711	5,239 Added 27.05%	24,607 $362,000
Q3 2023 Nov 13, 2023	BUY	$18.08 - $23.45 $100,488 - $130,335	5,558 Added 40.25%	19,368 $354,000
Q2 2023 Aug 10, 2023	BUY	$20.98 - $31.42 $18,273 - $27,366	871 Added 6.73%	13,810 $297,000
Q1 2023 May 11, 2023	BUY	$27.71 - $40.93 $358,539 - $529,593	12,939 New	12,939 $379,000

139

46.5M

226K

909K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.